Your browser doesn't support javascript.
loading
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring.
Gyawali, B; de Vries, E G E; Dafni, U; Amaral, T; Barriuso, J; Bogaerts, J; Calles, A; Curigliano, G; Gomez-Roca, C; Kiesewetter, B; Oosting, S; Passaro, A; Pentheroudakis, G; Piccart, M; Roitberg, F; Tabernero, J; Tarazona, N; Trapani, D; Wester, R; Zarkavelis, G; Zielinski, C; Zygoura, P; Cherny, N I.
Afiliação
  • Gyawali B; Department of Oncology, Queen's University, Kingston, Ontario, Canada; Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada; Division of Cancer Care and Epidemiology, Queen's University, Kingston, Ontario, Canada. Electronic address: gyawali.bishal@queensu.ca.
  • de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Dafni U; Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens; Frontier Science Foundation-Hellas, Athens, Greece.
  • Amaral T; Skin Cancer Center, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
  • Barriuso J; The Christie NHS Foundation Trust and Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Bogaerts J; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Calles A; Medical Oncology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain.
  • Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan; European Institute of Oncology, IRCCS, Milan, Italy.
  • Gomez-Roca C; Institut Universitaire du Cancer de Toulouse (IUCT), Toulouse, France.
  • Kiesewetter B; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Oosting S; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Passaro A; Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
  • Pentheroudakis G; ESMO Head Office, Lugano, Switzerland.
  • Piccart M; Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.
  • Roitberg F; WHO Cancer Management Consultant, Geneva, Switzerland; Instituto do Cancer do Estado de São Paulo (ICESP HCFMUSP), São Paulo, Brazil.
  • Tabernero J; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), UVic-UCC, IO-Quiron, Barcelona, Spain.
  • Tarazona N; Department of Medical Oncology, Biomedical Research Institute INCLIVA, CIBERONC, University of Valencia, Valencia, Spain.
  • Trapani D; European Institute of Oncology, IRCCS, Milan, Italy.
  • Wester R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Zarkavelis G; University of Ioannina-Department of Medical Oncology, Ioannina, Greece.
  • Zielinski C; Central European Cooperative Oncology Group and Central European Cancer Center, Wiener Privatklinik, Vienna, Austria.
  • Zygoura P; Frontier Science Foundation-Hellas, Athens, Greece.
  • Cherny NI; Cancer Pain and Palliative Medicine Service, Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
ESMO Open ; 6(3): 100117, 2021 06.
Article em En | MEDLINE | ID: mdl-33887690

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Análise de Dados / Neoplasias Tipo de estudo: Guideline / Health_technology_assessment / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Análise de Dados / Neoplasias Tipo de estudo: Guideline / Health_technology_assessment / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article